Is CTA safer than MRI or ultrasound for aorta checks?

The short version: CTA exposes you to radiation and iodinated contrast; MRI and ultrasound do not. Which is "safer" depends on what you are trying to avoid.

The core safety difference is not subtle. CTA uses ionizing radiation and requires injecting iodinated contrast dye, which can damage the kidneys and, in rare cases, trigger allergic reactions. A 2009 textbook states that CTA involves a "significant dose of ionizing radiation" and 20–50 mL of intravenous iodinated contrast [5]. A 2018 review on thoracic aortic imaging notes that contrast nephropathy risk should be considered, and that hydration or alternative imaging may be warranted [4]. MRI uses no radiation, but gadolinium-based contrast agents carry their own risk: nephrogenic systemic fibrosis in patients with advanced kidney disease, and the 2018 review advises caution when eGFR is below 30 [4]. A 2010 study of 3,444 patients receiving a specific gadolinium agent found a 0.93% adverse reaction rate, with higher rates in those with liver or kidney disorders [2].

Ultrasound uses no radiation and no nephrotoxic contrast. A 2011 study of 395 paired exams after aortic stent repair found that contrast-enhanced ultrasound (CEUS) was as accurate as CTA for detecting endoleaks and measuring aneurysm sac diameter, with the explicit advantage of reducing radiation and nephrotoxic risk [1]. The trade-off is that ultrasound is operator-dependent and can be limited by obesity, bowel gas, or ascites [1]. For routine monitoring of the aorta after repair, CEUS appears to match CTA's diagnostic performance without the ionizing radiation or contrast nephrotoxicity.

For a patient who needs repeated aortic checks, the evidence favors ultrasound or contrast-enhanced ultrasound as the safer option, matching CTA's accuracy for the most common follow-up questions [1]. CTA remains necessary when planning a reintervention [1]. MRI sits in the middle: no radiation, but gadolinium is not risk-free, especially for anyone with reduced kidney function [4].

My call: for routine monitoring, ultrasound (especially CEUS) is safer than CTA and equally effective for the key measurements. CTA is reserved for when you need the full anatomical map for a procedure. Confidence: moderate — the evidence covers EVAR follow-up well but does not directly compare all three modalities head-to-head for every aortic indication.